Fertility control

You have full text access to this OnlineOpen article

Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial

  1. S Wu1,
  2. EM Godfrey2,
  3. D Wojdyla3,
  4. J Dong1,
  5. J Cong1,
  6. C Wang4,
  7. H von Hertzen5

Article first published online: 7 JUL 2010

DOI: 10.1111/j.1471-0528.2010.02652.x

Issue

BJOG: An International Journal of Obstetrics & Gynaecology

BJOG: An International Journal of Obstetrics & Gynaecology

Volume 117, Issue 10, pages 1205–1210, September 2010

Additional Information

How to Cite

Wu, S., Godfrey, E., Wojdyla, D., Dong, J., Cong, J., Wang, C. and von Hertzen, H. (2010), Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. BJOG: An International Journal of Obstetrics & Gynaecology, 117: 1205–1210. doi: 10.1111/j.1471-0528.2010.02652.x

Author Information

  1. 1

    National Research Institute for Family Planning, Beijing, China

  2. 2

    Department of Family Medicine, University of Illinois College of Medicine, Chicago, IL, USA

  3. 3

    Centro Rosarino de Estudios Perinatales (CREP), Rosario, Argentina

  4. 4

    Qingdao Family Planning Research Institute, Qingdao, China

  5. 5

    UNDP/UNPFA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Geneva, Switzerland

*Dr EM Godfrey, Department of Family Medicine, University of Illinois College of Medicine, Chicago, IL 60612, USA. Email egodfrey@uic.edu

Publication History

  1. Issue published online: 16 AUG 2010
  2. Article first published online: 7 JUL 2010
  3. Accepted 28 May 2010. Published Online 7 July 2010.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (124K)

Keywords:

  • Copper T380A;
  • emergency contraception;
  • intrauterine contraception;
  • long-acting reversible contraception

Please cite this paper as: Wu S, Godfrey E, Wojdyla D, Dong J, Cong J, Wang C, von Hertzen H. Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. BJOG 2010;117:1205–1210.

Objective  To determine the effectiveness of the Copper T380A (CuT380A) intrauterine device (IUD) as an emergency contraceptive in women.

Design  Prospective, multicentre, cohort clinical trial.

Setting  Eighteen family planning clinics in China.

Sample  A cohort of 1963 women, aged 18–44 years, requesting emergency contraception within 120 hours of unprotected sexual intercourse.

Methods  Women requesting emergency contraception were followed at 1, 3 and 12 months after the insertion of CuT380A.

Main outcome measures  Efficacy of CuT380A as emergency contraception and for up to 12 months of postinsertion use. Insertion complication rates, reported side-effects and continuation rates at 12 months were also recorded.

Results  No pregnancies occurred prior to or at the first follow-up visit, making CuT380A 100% effective as emergency contraception in this study. The pregnancy rate over the 12-month period was 0.23 per 100 women. In all, 29 (1.5%) women experienced a difficult IUD insertion process, requiring local anaesthesia or prophylactic antibiotics. No uterine perforations occurred. The main side-effects were increased menstrual bleeding and menstrual disturbances. The 12-month postinsertion continuation rate was 94.0 per 100 woman-years.

Conclusions  CuT380A is a safe and effective method for emergency contraception. The advantages of CuT380A include its ability to provide effective, long-term contraception.

View Full Article (HTML) Get PDF (124K)